Stock PRON PRONOVA BIOPHARMA ASA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Pronova BioPharma ASA

Equities

PRON

NO0010382021

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pronova BioPharma : Probe Metals to Acquire 100% Interest in the Monique Property, Val-d’Or East Project, Quebec
PU
Pronova BioPharma : Probe Metals Completes $17 Million Bought Deal Private Placement
PU
Pronova BioPharma : Probe Metals Upsizes Bought Deal Private Placement to $17.0 Million
PU
Pronova BioPharma : Probe Metals Announces a $10 Million Bought Deal Private Placement of Flow-Through Units
PU
Pronova BioPharma ASA : Notification of large trade/mandatory notification of trade
PU
Pronova BioPharma AS : New Drug Application Approval for Lotriga® 2g in Japan
PU
Pronova BioPharma AS : Pronova BioPharma ASA: US District Court rules in Pronova BioPharma's favour on Lovaza(TM) patents
PU
Ex-dividend day for final dividend
FA
Pronova BioPharma AS : Pronova BioPharma ASA: Strong Progress Towards Diversification
PU
Pronova BioPharma AS : Pronova BioPharma ASA : Generic marketing authorisation in the UK
PU
Pronova BioPharma AS : Pronova BioPharma ASA: Pronova BioPharma has published its Annual Report 2011
PU
Pronova BioPharma AS : Presentation of Highlight Results from Phase 3 Trial of TAK-085 in Japan for the Treatment of Hyperlipidemia at the 76th Annual Scientific Meeting of the Japanese Circulation Society
PU
Pronova BioPharma AS : Pronova BioPharma ASA: Expanding the Pharmaceutical Business into Clinical Nutrition
PU
Pronova BioPharma AS : Pronova BioPharma ASA: Presentation of Q4 2011 results 14 February, 08:30 CET
PU
Pronova BioPharma AS : Pronova BioPharma ASA : Mandatory Notification of Trade
PU
Pronova BioPharma AS : Pronova BioPharma ASA: Strategic move into Omega-3 consumer market
PU
Pronova BioPharma AS : Pronova BioPharma launches Consumer Healthcare business
PU
Pronova BioPharma AS : Pronova BioPharma ASA : Presentation of Q3 2011 results 11 November, 08:30 AM CET
PU
Pronova BioPharma AS : Mandatory Notification of Trade
PU
Pronova BioPharma AS : PRC-4016 enters Phase I clinical trial for treatment of combined dyslipidemia
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRON Stock
  4. News Pronova BioPharma ASA